Purinergic signaling in infection and autoimmune disease

Biomedical Journal

Volumn 39, Issue 5, 2016, Pages 304-305

  Savio, Luiz Eduardo Baggio ^a   Coutinho Silva, Robson ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Chlamydia; NLRP3 inflammasome; P2X7 receptor; Purinergic receptors; Schistosoma mansoni; Systemic lupus erythematosus

Indexed keywords

CRYOPYRIN; INFLAMMASOME; PURINERGIC P2X7 RECEPTOR; PURINERGIC RECEPTOR; CARRIER PROTEIN;

AUTOIMMUNE DISEASE; BACTERIUM; CHLAMYDIASIS; EDITORIAL; EUKARYOTE; HOST; HUMAN; IMMUNOMODULATION; INFECTION; INFLAMMATION; MORBIDITY; NONHUMAN; PARASITE; PATHOGENESIS; PURINERGIC SIGNALING; SCHISTOSOMA; SCHISTOSOMIASIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; IMMUNOLOGY; METABOLISM;

AUTOIMMUNE DISEASES; CARRIER PROTEINS; HUMANS; INFLAMMASOMES; RECEPTORS, PURINERGIC P2X7; SIGNAL TRANSDUCTION;

EID: 85006056600     PISSN: 23194170     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bj.2016.09.002     Document Type: Editorial

References (17)

1. [1] Drury, A.N., Szent-Gyorgyi, A., The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J Physiol 68 (1929), 213–237.
2. [2] Holton, F.A., Holton, P., The capillary dilator substances in dry powders of spinal roots; a possible role of adenosine triphosphate in chemical transmission from nerve endings. J Physiol 126 (1954), 124–140.
3. [3] Holton, P., The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves. J Physiol 145 (1959), 494–504.
4. [4] Burnstock, G., Campbell, G., Satchell, D., Smythe, A., Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol 40 (1970), 668–688.
5. [5] Burnstock, G., Purinergic nerves. Pharmacol Rev 24 (1972), 509–581.
6. [6] Khakh, B.S., Burnstock, G., The double life of ATP. Sci Am 301 (2009), 84–90 92.
7. [7] Burnstock, G., Boeynaems, J.M., Purinergic signalling and immune cells. Purinergic Signal 10 (2014), 529–564.
8. [8] Dahlquist, R., Diamant, B., Further observations on ATP-induced histamine releasefrom rat mast cells. Acta Pharmacol Toxicol (Copenh), 28, 1970, 43.
9. [9] Cockcroft, S., Gomperts, B.D., The ATP4- receptor of rat mast cells. Biochem J 188 (1980), 789–798.
10. [10] Bours, M.J., Swennen, E.L., Di Virgilio, F., Cronstein, B.N., Dagnelie, P.C., Adenosine-5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112 (2006), 358–404.
11. [11] Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R.M., Curti, A., Idzko, M., et al. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176 (2006), 3877–3883.
12. [12] Di Virgilio, F., Purinergic signalling in the immune system. A brief update. Purinergic Signal 3 (2007), 1–3.
13. [13] McDonald, B., Pittman, K., Menezes, G.B., Hirota, S.A., Slaba, I., Waterhouse, C.C., et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330 (2010), 362–366.
14. [14] Coutinho-Silva, R., Ojcius, D.M., Role of extracellular nucleotides in the immune response against intracellular bacteria and protozoan parasites. Microbes Infect 14 (2012), 1271–1277.
15. [15] Pettengill, M.A., Abdul-Sater, A., Coutinho-Silva, R., Ojcius, D.M., Danger signals, inflammasomes, and the intricate intracellular lives of Chlamydiae. Biomed J 39 (2016), 306–315.
16. [16] Silva, C.L.M., Purinergic signaling in schistosomal infection. Biomed J 39 (2016), 316–325.
17. [17] Di Virgilio, F., Giuliani, A.L., Purinergic signalling in autoimmunity: A role for the P2X7R in systemic lupus erythematosus?. Biomed J 39 (2016), 326–338.